CW December 2004Issue Number 12 December 2004 ISSN 10593802 Adjuvant Chemotherapy for Breast Cancer PatientsAn epirubicin-based adjuvant regimen followed by docetaxel delivers a better disease-free and overall survival rate for node-positive breast cancer patients.
Go to Previous Page Go to Next Page Source & Additional Reading Presented at the 27th San Antonio Breast Cancer Symposium. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW December 2004Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |